Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial

Authors: Cedric Manlhiot, Jane W. Newburger, Tisiana Low, Nagib Dahdah, Andrew S. Mackie, Geetha Raghuveer, Therese M. Giglia, Frédéric Dallaire, Mathew Mathew, Kyle Runeckles, Elfriede Pahl, Ashraf S. Harahsheh, Kambiz Norozi, Sarah D. de Ferranti, Kevin Friedman, Anji T. Yetman, Shelby Kutty, Tapas Mondal, Brian W. McCrindle, Carolyn A. Altman, Brett R. Anderson, Elizabeth Braunlin, Jane C. Burns, Michael R. Carr, Nadine Choueiter, Jessica Colyer, Andrew Crean, Adam Dempsey, Laurent Desjardins, Rejane Dillenburg, Audrey Dionne, Anna Ferris, Michael H. Gewitz, Michelle M. Grcic, Steven C. Greenway, Elodie Hamel-Perrault, Kevin C. Harris, Christina Hayden‐Rush, Kevin D. Hill, Supriya Jain, Pei-Ni Jone, Thomas R. Kimball, Sean M. Lang, Jennifer S. Li, Ming‐Tai Lin, William T. Mahle, Kimberly E. McHugh, Michael A. Portman, Claudia Renaud, S. Kristen Sexson Tejitel, Jacqueline R. Szmuszkovicz, Karen Texter, Deepika Thacker, Elif Seda Selamet Tierney, Thomas Thomas, Adriana H. Tremoulet, Sharon Wagner‐Lees, Andrew Warren - Canadian Journal of Cardiology 2020 cited by 22